↓ Skip to main content

Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study

Overview of attention for article published in Journal of Translational Medicine, March 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
3 news outlets
blogs
1 blog
policy
1 policy source
twitter
57 X users
patent
1 patent
facebook
12 Facebook pages
wikipedia
3 Wikipedia pages
googleplus
3 Google+ users
reddit
2 Redditors

Readers on

mendeley
85 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study
Published in
Journal of Translational Medicine, March 2017
DOI 10.1186/s12967-017-1161-4
Pubmed ID
Authors

Brett A. Lidbury, Badia Kita, Donald P. Lewis, Susan Hayward, Helen Ludlow, Mark P. Hedger, David M. de Kretser

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 57 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 85 100%

Demographic breakdown

Readers by professional status Count As %
Other 10 12%
Student > Bachelor 10 12%
Researcher 9 11%
Student > Doctoral Student 7 8%
Student > Ph. D. Student 6 7%
Other 23 27%
Unknown 20 24%
Readers by discipline Count As %
Medicine and Dentistry 17 20%
Nursing and Health Professions 7 8%
Biochemistry, Genetics and Molecular Biology 6 7%
Neuroscience 6 7%
Agricultural and Biological Sciences 4 5%
Other 19 22%
Unknown 26 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 76. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 January 2024.
All research outputs
#601,582
of 26,614,447 outputs
Outputs from Journal of Translational Medicine
#127
of 4,890 outputs
Outputs of similar age
#11,995
of 327,541 outputs
Outputs of similar age from Journal of Translational Medicine
#5
of 66 outputs
Altmetric has tracked 26,614,447 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,890 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,541 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.